HEALTH● LOWJun 26 · Jun 26, 2026, 12:45 PM
Replimune Announces FDA Acceptance of RP1 Biologics License Application Resubmission for Advanced Melanoma
manilatimes.net · Philippines
Replimune announced that the FDA has accepted the resubmission of its RP1 Biologics License Application for treating advanced melanoma. This marks a step forward in the regulatory process for a potential new treatment.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
See it on the live mapPhilippines and nearby eventsMore from PhilippinesLatest stories and threat level
More from Philippines
DISASTERBREAKING4h agoPhilippines raises alert as Mayon Volcano eruptsAl Jazeera [en]CONFLICT23h agoChina accuses Philippines of setting up ‘obstacles’ to attending Asean defence meetingSouth China Morning PostMILITARY1d agoHegseth seeks to assuage Southeast Asian partners on trip to PhilippinesThe HillMILITARY1d agoHegseth pledges stronger military framework with Philippines, but lacks detailsSouth China Morning Post
More in Health
HEALTH45m agoEbola: Africa CDC mourns as DRC doctor dies from virusPremium TimesHEALTH1h agoWhich vaccinations should you have this autumn and which are recommended in GermanyEuroNews [en]HEALTH1h agoScientists confirm fruit and vegetable skin really is good for youNew ScientistHEALTH1h agoNipah medicine row: Action after receiving expert panel report, says Keralam Health MinisterThe Hindu